Nicole Kelsey - 01 Jul 2024 Form 3 Insider Report for AVITA Medical, Inc. (RCEL)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RCEL	Stock Options (Right to Buy)							01 Jul 2024	Common Stock	150,000	$7.72	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date of July 1, 2024.